Névine is a highly accomplished thought leader in the fields of biostatistics and data science with extensive experience across all phases of drug development. Névine had a 25-year career in senior roles at GlaxoSmithKline and AstraZeneca where she also led the Enterprise Data & Analytics initiative. She has been a key contributor to development strategies for over 200 drug projects across oncology, cardiovascular, metabolic, respiratory, inflammation, and renal diseases. She serves on the Scientific Advisory Board of ANOVA and was a Board member of CDISC for 6 years. She has been a reviewer for The Lancet and has over 25 peer reviewed publications to her name. She is currently a strategic consultant to several scientific data consortia (eg ctDNA, COVID19 Data Lab) and to the FDA (Office of the Principal Deputy Commissioner) on the application of real-world evidence to COVID19.